Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2003 Apr;58(4):357–360. doi: 10.1136/thorax.58.4.357

The pulmonary physician in critical care • Illustrative case 1: Cystic fibrosis

S Thomas 1
PMCID: PMC1746651  PMID: 12668804

Full Text

The Full Text of this article is available as a PDF (98.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brinson G. M., Noone P. G., Mauro M. A., Knowles M. R., Yankaskas J. R., Sandhu J. S., Jaques P. F. Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis. Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1951–1958. doi: 10.1164/ajrccm.157.6.9708067. [DOI] [PubMed] [Google Scholar]
  2. Ciofu Oana, Jensen Tim, Pressler Tacjana, Johansen Helle Krogh, Koch Christian, Høiby Niels. Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to beta-lactam antibiotics. Clin Microbiol Infect. 1996;2(2):91–98. doi: 10.1111/j.1469-0691.1996.tb00212.x. [DOI] [PubMed] [Google Scholar]
  3. Cohen A. M., Doershuk C. F., Stern R. C. Bronchial artery embolization to control hemoptysis in cystic fibrosis. Radiology. 1990 May;175(2):401–405. doi: 10.1148/radiology.175.2.2326467. [DOI] [PubMed] [Google Scholar]
  4. Davis P. B., di Sant'Agnese P. A. Assisted ventilation for patients with cystic fibrosis. JAMA. 1978 May 5;239(18):1851–1854. [PubMed] [Google Scholar]
  5. Freeman B. D., Isabella K., Lin N., Buchman T. G. A meta-analysis of prospective trials comparing percutaneous and surgical tracheostomy in critically ill patients. Chest. 2000 Nov;118(5):1412–1418. doi: 10.1378/chest.118.5.1412. [DOI] [PubMed] [Google Scholar]
  6. Fuchs H. J., Borowitz D. S., Christiansen D. H., Morris E. M., Nash M. L., Ramsey B. W., Rosenstein B. J., Smith A. L., Wohl M. E. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med. 1994 Sep 8;331(10):637–642. doi: 10.1056/NEJM199409083311003. [DOI] [PubMed] [Google Scholar]
  7. Garland J. S., Chan Y. M., Kelly K. J., Rice T. B. Outcome of infants with cystic fibrosis requiring mechanical ventilation for respiratory failure. Chest. 1989 Jul;96(1):136–138. doi: 10.1378/chest.96.1.136. [DOI] [PubMed] [Google Scholar]
  8. Graff G. R. Treatment of recurrent severe hemoptysis in cystic fibrosis with tranexamic acid. Respiration. 2001;68(1):91–94. doi: 10.1159/000050470. [DOI] [PubMed] [Google Scholar]
  9. Hodson M. E., Madden B. P., Steven M. H., Tsang V. T., Yacoub M. H. Non-invasive mechanical ventilation for cystic fibrosis patients--a potential bridge to transplantation. Eur Respir J. 1991 May;4(5):524–527. [PubMed] [Google Scholar]
  10. Hodson M. E., Mearns M. B., Batten J. C. Meconium ileus equivalent in adults with cystic fibrosis of pancreas: a report of six cases. Br Med J. 1976 Oct 2;2(6039):790–791. doi: 10.1136/bmj.2.6039.790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ivanick M. J., Thorwarth W., Donohue J., Mandell V., Delany D., Jaques P. F. Infarction of the left main-stem bronchus: a complication of bronchial artery embolization. AJR Am J Roentgenol. 1983 Sep;141(3):535–537. doi: 10.2214/ajr.141.3.535. [DOI] [PubMed] [Google Scholar]
  12. Lanng S., Thorsteinsson B., Lund-Andersen C., Nerup J., Schiøtz P. O., Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr. 1994 Jan;83(1):72–77. doi: 10.1111/j.1651-2227.1994.tb12956.x. [DOI] [PubMed] [Google Scholar]
  13. Lemoigne F., Rampal P., Petersen R. Colite ischemique fatale après embolisation artérielle bronchique. Presse Med. 1983 Sep 24;12(33):2056–2057. [PubMed] [Google Scholar]
  14. Madden B. P., Kariyawasam H., Siddiqi A. J., Machin A., Pryor J. A., Hodson M. E. Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure. Eur Respir J. 2002 Feb;19(2):310–313. doi: 10.1183/09031936.02.00218502. [DOI] [PubMed] [Google Scholar]
  15. Massard G., Shennib H., Metras D., Camboulives J., Viard L., Mulder D. S., Tchervenkov C. I., Morin J. F., Giudicelli R., Noirclerc M. Double-lung transplantation in mechanically ventilated patients with cystic fibrosis. Ann Thorac Surg. 1993 May;55(5):1087–1092. doi: 10.1016/0003-4975(93)90012-7. [DOI] [PubMed] [Google Scholar]
  16. Master V., Roberts G. W., Coulthard K. P., Baghurst P. A., Martin A., Roberts M. E., Onishko C. R., Martin A. J., Linke R. J., Holmes M. Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study. Pediatr Pulmonol. 2001 May;31(5):367–376. doi: 10.1002/ppul.1060. [DOI] [PubMed] [Google Scholar]
  17. Minkes R. K., Langer J. C., Skinner M. A., Foglia R. P., O'Hagan A., Cohen A. H., Mallory G. B., Huddleston C. B., Mendeloff E. N. Intestinal obstruction after lung transplantation in children with cystic fibrosis. J Pediatr Surg. 1999 Oct;34(10):1489–1493. doi: 10.1016/s0022-3468(99)90110-0. [DOI] [PubMed] [Google Scholar]
  18. Nagel R. A., Westaby D., Javaid A., Kavani J., Meire H. B., Lombard M. G., Wise A., Williams R., Hodson M. E. Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet. 1989 Dec 16;2(8677):1422–1425. doi: 10.1016/s0140-6736(89)92035-7. [DOI] [PubMed] [Google Scholar]
  19. Quan J. M., Tiddens H. A., Sy J. P., McKenzie S. G., Montgomery M. D., Robinson P. J., Wohl M. E., Konstan M. W., Pulmozyme Early Intervention Trial Study Group A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. J Pediatr. 2001 Dec;139(6):813–820. doi: 10.1067/mpd.2001.118570. [DOI] [PubMed] [Google Scholar]
  20. Schidlow D. V., Taussig L. M., Knowles M. R. Cystic Fibrosis Foundation consensus conference report on pulmonary complications of cystic fibrosis. Pediatr Pulmonol. 1993 Mar;15(3):187–198. doi: 10.1002/ppul.1950150311. [DOI] [PubMed] [Google Scholar]
  21. Shah P. I., Bush A., Canny G. J., Colin A. A., Fuchs H. J., Geddes D. M., Johnson C. A., Light M. C., Scott S. F., Tullis D. E. Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment. Eur Respir J. 1995 Jun;8(6):954–958. [PubMed] [Google Scholar]
  22. Stead R. J., Kennedy H. G., Hodson M. E., Batten J. C. Adverse reactions to piperacillin in adults with cystic fibrosis. Thorax. 1985 Mar;40(3):184–186. doi: 10.1136/thx.40.3.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tonkin I. L., Hanissian A. S., Boulden T. F., Baum S. L., Gavant M. L., Gold R. E., George P., Green W. J. Bronchial arteriography and embolotherapy for hemoptysis in patients with cystic fibrosis. Cardiovasc Intervent Radiol. 1991 Jul-Aug;14(4):241–246. doi: 10.1007/BF02578470. [DOI] [PubMed] [Google Scholar]
  24. Whitehead A., Conway S. P., Etherington C., Caldwell N. A., Setchfield N., Bogle S. Once-daily tobramycin in the treatment of adult patients with cystic fibrosis. Eur Respir J. 2002 Feb;19(2):303–309. doi: 10.1183/09031936.02.00221602. [DOI] [PubMed] [Google Scholar]
  25. van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359–1367. doi: 10.1056/NEJMoa011300. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES